Cart
sales@molnova.com
CB1 antagonist 2
CAS No. 614726-85-1
CB1 antagonist 2( AM4113 )
Catalog No. M24614 CAS No. 614726-85-1
CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 33 | In Stock |
|
| 5MG | 53 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 174 | In Stock |
|
| 50MG | 335 | In Stock |
|
| 100MG | 500 | In Stock |
|
| 500MG | 1098 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCB1 antagonist 2
-
NoteResearch use only, not for human use.
-
Brief DescriptionCB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.
-
DescriptionCB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.
-
In Vitro——
-
In Vivo——
-
SynonymsAM4113
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCB1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number614726-85-1
-
Formula Weight380.66
-
Molecular FormulaC17H12Cl3N3O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 60 mg/mL (157.62 mM; Need ultrasonic); H2O: < 0.1 mg/mL (insoluble)
-
SMILESCc1c(-c(cc2)ccc2Cl)n(-c(ccc(Cl)c2)c2Cl)nc1C(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Li, S. , et al. "4-methyl-1h-diaryl pyrazole derivatives and their uses as medicament." WO, WO2007121687 A1.
molnova catalog
related products
-
Taranabant
A potent, selective and orally active cannabinoid-1 receptor (CB1R) inverse agonist with IC50 of 2.8 nM, Ki of 0.13 nM.
-
TM38837
TM38837 is an antagonist of cannabinoid receptor type 1 (CB1), with potential for the treatment of obesity and type 2 diabetes.
-
AM6545
AM6545 is a selective and potent peripheral restricted cannabinoid receptor 1 (CB1) antagonist that inhibits the CB2 receptor, ameliorates hypometabolic obesity and improves adipokine secretion in monosodium glutamate-induced obese mice, and may be useful in the study of obesity and diabetes.
